China Pharma Holdings (CPHI) Assets Average (2011 - 2026)

China Pharma Holdings (CPHI) has reported Assets Average for 16 consecutive years, with $44.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average rose 221.09% year-over-year to $44.9 million; the trailing twelve-month figure through Jun 2026 stood at $44.9 million (up 221.09% YoY), and the FY2025 full-year result was $22.9 million, up 46.34% from the prior year.
• Assets Average climbed to $44.9 million in Q2 2026 per CPHI's latest filing, from $38.1 million in the prior quarter.
• Across five years, Assets Average topped out at $44.9 million in Q2 2026 and bottomed at $13.9 million in Q3 2024.
• Historically, Assets Average has averaged $19.5 million across 5 years, with a median of $16.4 million in 2023.
• The sharpest annual moves came in 2023 and 2026: Assets Average fell 19.57% in 2023, then soared 221.09% in 2026.
• Over 5 years, Assets Average stood at $17.0 million in 2022, then slipped by 6.37% to $15.9 million in 2023, then dropped by 10.9% to $14.2 million in 2024, then jumped by 65.08% to $23.4 million in 2025, then surged by 91.98% to $44.9 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $44.9 million, $38.1 million, and $23.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.